Levi & Korsinsky, LLP announces that a TWST class action lawsuit has been filed on behalf of investors who purchased Twist Bioscience Corporation (TWST) securities between December 13, 2019, and November 14, 2022. For more on the TWST Lawsuit please contact us today.

According to the Twist Bioscience lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: 1) as alleged in the November 15, 2022 report by Scorpion Capital, defendants overstated the commercial viability of Twist’s synthetic DNA manufacturing technology, and 2) at the same time, defendants were engaging in accounting fraud and using unsustainable pricing to inflate the Company’s true financial condition and prospects.

TO LEARN MORE ABOUT THE TWST CLASS ACTION LAWSUIT, CLICK HERE

If you suffered a loss in Twist Bioscience you have until February 10, 2023, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com